4572 — Carna Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00
- ¥8bn
- ¥5bn
- ¥2bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 913 | -1,102 | -532 | -1,323 | -1,131 |
Depreciation | |||||
Non-Cash Items | 108 | 94.5 | 57.7 | 84.6 | 47.4 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 448 | -265 | -1,081 | 497 | -630 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 1,478 | -1,261 | -1,537 | -708 | -1,677 |
Capital Expenditures | -42 | -68.9 | -41.7 | -126 | -11.5 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 1.09 | -1.58 | — | 0.305 | 0.154 |
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -40.9 | -70.4 | -41.7 | -126 | -11.4 |
Financing Cash Flow Items | 7.85 | — | 5.64 | 5.71 | -9.29 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 2,122 | 724 | 1,065 | 367 | 1,182 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 3,560 | -616 | -481 | -439 | -490 |